Phase 3 Coronary Clinical Trials
49 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–20 of 49 trials
Recruiting
Phase 3
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Coronary Artery Disease ProgressionPremature AtherosclerosisCoronary Artery Disease Risk Factors Multiple+1 more
Duke University1,500 enrolled23 locationsNCT07232069
Recruiting
Phase 3
Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)
Chronic Coronary SyndromeStable Coronary Artery Disease CAD
Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.1,703 enrolled18 locationsNCT07195149
Recruiting
Phase 3
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
Acute Coronary Syndrome
Novartis Pharmaceuticals300 enrolled63 locationsNCT07102628
Recruiting
Phase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
DalCor Pharmaceuticals2,000 enrolled231 locationsNCT05918861
Recruiting
Phase 3
Statins Study in Children of Acute Kawasaki Disease With Coronary Artery Abnormalities
Kawasaki DiseaseCoronary Artery Abnormalities
Children's Hospital of Fudan University9 enrolled1 locationNCT07530640
Recruiting
Phase 3
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
Acute Coronary SyndromeTuberculosisPulmonary Hypertension (Diagnosis)
National University Hospital, Singapore150 enrolled6 locationsNCT05473520
Recruiting
Phase 3
Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute Coronary Syndrome Patients With Pneumonia, With or Without Influenza Vaccination
PneumoniaCOPD, Chronic Obstructive Pulmonary Diseaseacute coronary syndromes (ACS)
University of Brawijaya60 enrolled1 locationNCT07604103
Recruiting
Phase 3
Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
Coronary Artery DiseasePercutaneous Coronary InterventionAcute Coronary Syndromes+3 more
Cardiocentro Ticino355 enrolled1 locationNCT07582835
Recruiting
Phase 2Phase 3
Canagliflozin Targeting Vascular Inflammation
Coronary Artery DiseaseDiabetes Type 2
Ottawa Heart Institute Research Corporation24 enrolled1 locationNCT05427084
Recruiting
Phase 3
Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction
Coronary Artery DiseaseAcute Myocardial Infarction (AMI)Coronary Atherosclerosis of Native Coronary Artery
ECRI bv332 enrolled1 locationNCT07276282
Recruiting
Phase 3
Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR)
Coronary Artery Disease (CAD)
Sinotau Pharmaceutical Group395 enrolled5 locationsNCT07439133
Recruiting
Phase 3
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
Coronary Artery Disease
MedTrace Pharma A/S215 enrolled14 locationsNCT05134012
Recruiting
Phase 3
One-Month DAPT in CABG Patients
Chronic Coronary Disease
Weill Medical College of Cornell University700 enrolled22 locationsNCT05997693
Recruiting
Phase 2Phase 3
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
Heart FailureAcute Kidney InjuryPercutaneous Coronary Intervention+2 more
VA Office of Research and Development240 enrolled3 locationsNCT04982419
Recruiting
Phase 3
Desflurane vs. Propofol for Cardiac Anesthesia
Coronary Artery Bypass GraftingCardiac Surgery
Xijing Hospital3,560 enrolled14 locationsNCT07116733
Not Yet Recruiting
Phase 3Phase 4
COMparative Pharmacotherapy And peRsonalised stratEgy in the management of Coronary Microvascular Dysfunction double blind randomised controlled Trial - Part 1
Angina with non obstructive coronary artery disease
Sydney Local Health District130 enrolled2 locationsACTRN12625001179426
Not Yet Recruiting
Phase 3Phase 4
COMparative Pharmacotherapy And peRsonalised stratEgy in the management of Coronary Microvascular Dysfunction double blind randomised controlled Trial - Part II
Angina with non obstructive coronary artery disease
Sydney Local Health District130 enrolled2 locationsACTRN12625001174471
Not Yet Recruiting
Phase 3
PDE-5 inhibition in Ischaemia with Non-Obstructive Coronary Arteries: a double-blinded, randomised, placebo-controlled trial (PERTINENT)
IschaemiaNon obstructive coronary artery disease
Sydney Local Health District30 enrolled1 locationACTRN12625001161415
Recruiting
Phase 3
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
Coronary Artery Disease
Weill Medical College of Cornell University600 enrolled18 locationsNCT06399705
Recruiting
Phase 3
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
Coronary Artery Disease
Weill Medical College of Cornell University600 enrolled18 locationsNCT06399692